Neuberger Berman Group
AGL icon

Neuberger Berman Group’s Agilon Health AGL Stock Holding History

Neuberger Berman Group’s Portfolio AGL Stock Details AGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-520
Closed -$8.95K – 2163
2025
Q4 		$8.95K Buy
520
+34
+7% +$659 ﹤0.01% 2105
2025
Q3 		$12.5K Buy
+486
New +$18.4K ﹤0.01% 2025
2025
Q2 		– Sell
-426
Closed -$46.1K – 2052
2025
Q1 		$46.1K Sell
426
-118
-22% -$10.3K ﹤0.01% 1918
2024
Q4 		$25.9K Sell
544
-2
-0.4% -$121 ﹤0.01% 1905
2024
Q3 		$53.6K Buy
546
+101
+23% +$13K ﹤0.01% 1870
2024
Q2 		$72.7K Sell
445
-513
-54% -$73.1K ﹤0.01% 1828
2024
Q1 		$146K Sell
958
-733
-43% -$122K ﹤0.01% 1770
2023
Q4 		$530K Buy
1,691
+858
+103% +$311K ﹤0.01% 1688
2023
Q3 		$370K Buy
833
+341
+69% +$154K ﹤0.01% 1531
2023
Q2 		$213K Buy
492
+48
+11% +$27K ﹤0.01% 1688
2023
Q1 		$264K Buy
444
+4
+0.9% +$2.24K ﹤0.01% 1642
2022
Q4 		$178K Sell
440
-17
-4% -$7.97K ﹤0.01% 1698
2022
Q3 		$267K Hold
457
– – ﹤0.01% 1643
2022
Q2 		$250K Buy
457
+11
+2% +$5.56K ﹤0.01% 1697
2022
Q1 		$283K Buy
+446
New +$230K ﹤0.01% 1723

Other funds holding AGL

CDR
Clayton Dubilier & Rice New York $895M AUM 792.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
NPCM
North Peak Capital Management New York $900M AUM 193.67% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return

Neuberger Berman Group's AGL Position: Q1 2026 in Review

Neuberger Berman Group sold out of Agilon Health (AGL) in Q1 2026, closing a stake of 520 shares — an estimated $8.95K sold.

Neuberger Berman Group first reported a position in AGL in Q1 2022 and held it in 15 quarters. The position peaked at $530K in Q4 2023. 97 funds tracked by Wall St. Rank hold AGL as of Q1 2026.

  • Neuberger Berman Group reported no remaining Agilon Health position as of Q1 2026 after selling out during the quarter.
  • Neuberger Berman Group sold 520 Agilon Health shares in Q1 2026, an estimated $8.95K.
  • Neuberger Berman Group first reported a position in Agilon Health in Q1 2022 and held it in 15 quarters.
  • Neuberger Berman Group's Agilon Health position peaked at $530K in Q4 2023.
  • 97 funds tracked by Wall St. Rank held Agilon Health as of Q1 2026.

Based on Neuberger Berman Group's 13F filing for Q1 2026, filed 14 May 2026.